Tracon Pharmaceuticals Inc (TCON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,270 | 7,891 | 8,564 | 7,763 | 1,735 |
| Receivables | N/A | N/A | N/A | N/A | 9,000 |
| TOTAL | $6,510 | $8,402 | $9,090 | $8,340 | $10,991 |
| Non-Current Assets | |||||
| PPE Net | 30 | 33 | 37 | 40 | 44 |
| Other Non-Current Assets | 860 | 920 | 978 | 1,033 | 1,155 |
| TOTAL | $890 | $953 | $1,015 | $1,073 | $1,199 |
| Total Assets | $7,400 | $9,355 | $10,105 | $9,413 | $12,190 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,652 | 2,681 | 2,544 | 10,622 | 26,042 |
| Accrued Expenses | 7,239 | 7,769 | 7,638 | 1,080 | 1,031 |
| TOTAL | $9,891 | $10,450 | $10,182 | $11,702 | $27,073 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 598 | 667 | 732 | 795 | 856 |
| TOTAL | $598 | $667 | $732 | $795 | $856 |
| Total Liabilities | $10,489 | $11,117 | $10,914 | $12,497 | $27,929 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,408 | 2,679 | 2,275 | 1,557 | 1,535 |
| Common Shares | 3 | 3 | 2 | 31 | 27 |
| Retained earnings | -246,506 | -243,667 | -240,499 | -240,938 | -251,701 |
| TOTAL | $-3,089 | $-1,762 | $-809 | $-3,084 | $-15,739 |
| Total Liabilities And Equity | $7,400 | $9,355 | $10,105 | $9,413 | $12,190 |